Abstract
Purpose
Accumulating clinical evidence indicates the risk of tendinopathy and spontaneous and/or simultaneous tendon ruptures associated with statin use. This experimental study was designed to evaluate and compare the biomechanical and histopathological effects of the three most commonly prescribed statins (simvastatin, atorvastatin and rosuvastatin) on the Achilles tendon in rats.
Methods
Statins were administered by gavage to rats at daily doses of 20 and 40 mg/kg for 3 weeks. One week later, the Achilles tendons were dissected and their biomechanical properties, including ultimate tensile force, yield force and elastic modulus, were determined. The samples were stained with haematoxylin–eosin and examined under a light microscope. The biomechanical properties of the tibia were tested by three-point bending test. Bone mineral density (BMD) and the lengths of tibias were measured by computed tomography.
Results
All the statins caused deterioration of the biomechanical parameters of the Achilles tendon. Histopathological analysis demonstrated foci of dystrophic calcification only in the statin-treated groups. However, the number and the total area of calcific deposits were similar between the statin groups. The biomechanical parameters of tibias were improved in all the statin groups. BMD in the statin-treated groups was not significantly different from the control group.
Conclusion
All the statins tested are associated with calcific tendinopathy risk of which full awareness is required during everyday medical practice. However, statin-associated improvement of bone biomechanical properties is a favourable feature which may add to their beneficial effects in atherosclerotic cardiovascular disease, especially in the elderly.
Similar content being viewed by others
References
Beri A, Dwamena FC, Dwamena BA (2009) Association between statin therapy and tendon rupture: a case-control study. J Cardiovasc Pharmacol 53:401–404
Beri A, Khattri S (2008) Tendon rupture and statin therapy: is there a link? Comment on the article by Marie et al. Arthritis Rheum 59:1202
Carmont MR, Highland AM, Blundell CM, Davies MB (2009) Simultaneous bilateral Achilles tendon ruptures associated with statin medication despite regular rock climbing exercise. Phys Ther Sport 10:150–152
Celik EC, Ozbaydar M, Ofluoglu D, Demircay E (2012) Simultaneous and spontaneous bilateral quadriceps tendons rupture. Am J Phys Med Rehabil 91:631–634
Chazerain P, Hayem G, Hamza S, Best C, Ziza JM (2001) Four cases of tendinopathy in patients on statin therapy. Joint Bone Spine 68:430–433
Choudhry NKDS, Shrank WH, Polinski JM, Stark CE, Gupta R, Prabhakaran D, Brill G, Jha P (2014) Despite increased use and sales of statins in India, per capita prescription rates remain far below high-income countries. Health Aff (Millwood) 33:273–282
Conforti ACC, Moretti U, Colcera S, Fumagalli G, Leone R (2007) Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases. Curr Drug Saf 2:47–63
de Oliveira LP, Vieira CP, Da Ré Guerra F, de Almeida Mdos S, Pimentel ER (2013) Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology 311:162–168
de Oliveira LP, Vieira CP, Guerra FD, Almeida MS, Pimentel ER (2015) Structural and biomechanical changes in the Achilles tendon after chronic treatment with statins. Food Chem Toxicol 77:50–57
Dolkart O, Liron T, Chechik O, Somjen D, Brosh T, Maman E, Gabet Y (2014) Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study. Am J Sports Med 42:2869–2876
Fernandez G, Spatz ES, Jablecki C, Phillips PS (2011) Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med 78:393–403
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (2014) What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol 21:464–474
García MJ, Reinoso RF, Sánchez-Navarro A, Prous JR (2003) Clinical pharmacokinetics of statins. Methods Find Exp Clin Pharmacol 25:457–481
Hoffman KB, Kraus C, Dimbil M, Golomb BA (2012) A survey of the FDA’s AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One 7:e42866
Ioannidis JP (2014) More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines. JAMA 311:463–464. doi:10.1001/jama.2013.284657
Itagaki M, Takaguri A, Kano S, Kaneta S, Ichihara K, Satoh K (2009) Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats. J Pharmacol Sci 109:94–101
Kaleagasioglu F, Olcay E (2012) Fluoroquinolone-induced tendinopathy: etiology and preventive measures. Tohoku J Exp Med 226:251–258
Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, Lecouvet F, Vande Berg B, Djebbar S, Dallaudière B (2014) Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine. doi:10.1016/j.jbspin.2014.03.022
Klopstock T (2008) Drug-induced myopathies. Curr Opin Neurol 21:590–595
Liantonio A, Giannuzzi V, Cippone V, Camerino GM, Pierno S, Camerino DC (2007) Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system. J Pharmacol Exp Ther 321:626–634
Lui PP (2013) Histopathological changes in tendinopathy–potential roles of BMPs? Rheumatology (Oxford) 52:2116–2126
MacDonald JS, Halleck MM (2004) The toxicology of HMG-CoA reductase inhibitors: prediction of human risk. Toxicol Pathol 32:26–41
Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S (2014) Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med 12:51
Marie I, Delafenêtre H, Massy N, Thuillez C, Noblet C, NotFP Centers (2008) Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Rheum 59:367–372
Maritz FJ, Conradie MM, Hulley PA, Gopal R, Hough S (2001) Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol 21:1636–1641
Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620
Movahed MR, Samsamsharaiat SA (2006) Reproducible tendinitis-like symptoms related to statin therapy. J Clin Rheumatol 12:320–321
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946–1949
Olcay E, Beytemur O, Kaleagasioglu F, Gulmez T, Mutlu Z, Olgac V (2011) Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats. J Toxicol Sci 36:339–345
Oliva F, Via AG, Maffulli N (2012) Physiopathology of intratendinous calcific deposition. BMC Med 10:95
Pedersen T, Gaw A (2001) Statins–similarities and differences. Am J Manag Care 7:S132–S137
Pullatt RC, Gadarla MR, Karas RH, Alsheikh-Ali AA, Thompson PD (2007) Tendon rupture associated with simvastatin/ezetimibe therapy. Am J Cardiol 100:152–153
Rubin G, Haddad E, Ben-Haim T, Elmalach I, Rozen N (2011) Bilateral, simultaneous rupture of the quadriceps tendon associated with simvastatin. Isr Med Assoc J 13:185–186
Sakamoto K, Kimura J (2013) Mechanism of statin-induced rhabdomyolysis. J Pharmacol Sci 123:289–294
Savvidou CMR (2012) Spontaneous distal biceps tendon ruptures: are they related to statin administration? Hand Surg 17:167–171
Schachter M (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19:117–125
Stone NJ, Robinson JG, Lichtenstein AH, Bairey MCN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SCJ, Watson K, Wilson PW (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation 129:S1–S45
Tsartsalis AN, Dokos C, Kaiafa GD, Tsartsalis DN, Kattamis A, Hatzitolios AI, Savopoulos CG (2012) Statins, bone formation and osteoporosis: hope or hype? Hormones (Athens) 11:126–139
Westwood FR, Bigley A, Randall K, Marsden AM, Scott RC (2005) Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol 33:246–257
Young JS, Maffuli N (2007) Etiology and epidemiology of Achilles tendon problems. In: Maffuli N, Almekinders LC (eds) The Achilles tendon. Springer, London, pp 39–49
Acknowledgments
The funding support from Turkish Society of Orthopaedics and Traumatology (TOTBID) for this work is gratefully acknowledged.
Author contribution
This research project was designed and conducted by F. Kaleağasıoğlu and E. Olcay who also interpreted the data, drafted the paper and revised it critically. V. Olgac conducted and interpreted the pathological analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Additional information
Ferda Kaleağasıoğlu and Ercan Olcay have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kaleağasıoğlu, F., Olcay, E. & Olgaç, V. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin. Knee Surg Sports Traumatol Arthrosc 25, 1884–1891 (2017). https://doi.org/10.1007/s00167-015-3728-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-015-3728-z